Skip to main content
Fig. 7 | Clinical Epigenetics

Fig. 7

From: Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma

Fig. 7

TGFBR2 overexpression inhibits tumor growth in vivo. a Tumor volume as measured in xenografts over 21 days derived from KYSE-150-vector (WT) and KYSE-150-TGFBR2 (OE) cells. b Image of subcutaneous xenografts derived from the cells indicated after growth in vivo for 3 weeks. c Tumor weight associated with WT- and OE-derived xenografts at 21 days. d IHC reveals the expression of TGFBR2 and CK in WT and OE cell xenografts

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us